Mahoney David L's Form 4 filing
Corcept Therapeutics Inc (CORT) · filed Aug 20, 2026
- Accession no.
- 0001193125-26-359255
- Filed
- Aug 20, 2026, 4:30 PM ET
- Trade date
- Aug 18, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $12.3M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mahoney David LCIK 0001224091 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | Common Stock | SSaleDisposed | −4,984 | $117.47 | −$585,478.45 | 1,232,161 | Indirect | |
| Aug 18, 2026 | Common Stock | SSaleDisposed | −91,167 | $118.24 | −$10,779,367.28 | 1,140,994 | Indirect | |
| Aug 18, 2026 | Common Stock | SSaleDisposed | −7,055 | $118.88 | −$838,710.39 | 1,133,939 | Indirect | |
| Aug 18, 2026 | Common Stock | SSaleDisposed | −400 | $119.64 | −$47,855.24 | 1,133,539 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.